Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad

The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23

We haven't written up this one. The Hindu has the full story — the link below goes straight to it.

Read the original at thehindu.com →

More in Health & Medicine

More from Saturday 24 October →